United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026
Go back to United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 536.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $536.59 | 52 Week High | $164.04 | |||
| Open | $536.59 | 52 Week Low | $97.52 | |||
| Day High | $536.59 | P/E | 98.10 | |||
| Day Low | $536.59 | EPS | $5.47 | |||
| Volume | 214 | |||||
